EFCG main achievements are:

- Regularly in contact with the FDA for GDUFA II;

- cooperation with EGA on common issues;

- A role, through CEFIC, in TTIP;

- Presidency of Rx-360;

- A role in the FMD (Falsified Medicines Directive);

- Regular meetings with the European Commission and EMA;

- Market Survey;

- A successful Annual Dinner;

- Memorandum of Understanding between EFCG and IPEC for excipients.  

You are here: EFCG > About Us > Achievements

Latest News

  • In 2004 EFCG raised the first red flags about sub-standard Active Pharmaceutical Ingredients (APIs) entering Europe from India and China. Twelve years on, it appears that risks to patients from non-compliant bad quality APIs have been substantially reduced and that the playing field is levelling out.


  • EFCG Press Conference CPhI 2015: "API" day for Europe as Big Pharma returns in search of quality (by Dan Stanton)


  • EFCG Press Conference CPhI 2015: Outlook in Europe for API Manufacturers is positive, says EFCG


Access News Archive

Website Developers - Deep Blue Sky